Live Analyst Rating Changes 1526 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Tom Mackinnon
BMO
Tom Mackinnon
BMO Capital
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-51.3%
Average Return
0 of 2 calls profitable · -25522.6% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 0% of Tom Mackinnon's ratings turned a profit when each position was held for 1 year — averaging -51.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

23 Buy 30 Hold 0 Sell
Tom's Stock Coverage 17 ratings · 2026-06-21
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TSE:POW
Power Corp of Canada
 May 14, 2026 HOLD Hold
-19.0% avg upside
11 analysts
$80.00
10.15% Downside
 ·
TSE:MFC
Manulife Financial
 May 14, 2026 BUY Strong Buy
-1.3% avg upside
14 analysts
$57.00
0.10% Downside
 ·
TSE:GWO
Great-West Lifeco
 May 08, 2026 HOLD Hold
-17.2% avg upside
9 analysts
$76.00
13.77% Downside
 ·
TSE:SLF
Sun Life Financial
 May 08, 2026 BUY Buy
-10.4% avg upside
17 analysts
$105.00
4.13% Downside
 ·
TSE:IGM
IGM Financial
 Apr 29, 2026 HOLD Buy
-15.7% avg upside
11 analysts
$72.00
10.61% Downside
 ·
TSE:AGF.B
AGF Management B NV
 Apr 14, 2026 HOLD Sell
-26.6% avg upside
10 analysts
$20.00
1.11% Downside
 ·
TSE:FFH
Fairfax Financial Holdings
 Mar 10, 2026 HOLD Strong Buy
+16.4% avg upside
8 analysts
$2500.00
11.64% Upside
 ·
TSE:IAG
iA Financial Corporation Inc
 Feb 19, 2026 BUY Hold
-9.4% avg upside
7 analysts
$175.00
7.69% Downside
 ·
TSE:TSU
Trisura Group Ltd
 Feb 17, 2026 BUY Strong Buy
+39.3% avg upside
10 analysts
$59.00
39.11% Upside
 ·
TSE:EFN
Element Fleet Management
 Nov 13, 2025 BUY Strong Buy
+20.9% avg upside
15 analysts
$40.00
42.06% Upside
 ·
TSE:DFY
Definity Financial Corp.
 Nov 07, 2025 HOLD Buy
+8.0% avg upside
11 analysts
$73.00
1.24% Upside
 ·
TSE:IFC
Intact Financial Corporation
 Nov 05, 2025 BUY Buy
+0.0% avg upside
17 analysts
$320.00
15.13% Upside
 ·
BTAI
Bioxcel Therapeutics
 Aug 15, 2023 HOLD Buy
+1918.5% avg upside
12 analysts
$4.00
233.36% Upside
 -83.6%
GNW
Genworth Financial
 Feb 09, 2017 BUY Buy
+77.6% avg upside
10 analysts
$40.00
346.83% Upside
 -19.1%
TSE:LB
Laurentian Bank
 Sep 26, 2016 HOLD Hold
+13.9% avg upside
11 analysts
$73.59
82.41% Upside
 ·
TSE:NA
National Bank of Canada
 Sep 22, 2016 HOLD Buy
-18.2% avg upside
14 analysts
$69.35
68.64% Downside
 ·
TSE:CM
Canadian Bank of Commerce
 Sep 22, 2016 HOLD Strong Buy
-5.5% avg upside
16 analysts
$145.77
9.15% Downside
 ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Tom Mackinnon — Frequently Asked Questions
How accurate are Tom Mackinnon's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Tom's ratings were profitable over a one-year hold, with an average return of -51.3% per rating, or -25522.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Tom ranked on 13Foresight?
Tom Mackinnon is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Tom cover?
Tom most recently has ratings on TSE:POW, TSE:MFC, TSE:GWO, TSE:SLF, TSE:IGM, TSE:AGF.B, TSE:FFH, TSE:IAG, TSE:TSU, TSE:EFN, TSE:DFY, TSE:IFC and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.